The leading market experts have placed a mean price target of $52.51 on Amedisys Inc (NASDAQ:AMED) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.46 a share for the upcoming quarter and $1.74 for the current fiscal. Technical View The technical analysis of Amedisys Inc plainly substantiates that the 50-day moving average of Amedisys Inc is $51.28, and stock is hovering 2.14 or +4.16% distant from $51.28. It is noted that the 200-day MA is $45.52, and Amedisys Inc stock is $7.90 or +17.34% off from this point. Amedisys Inc (NASDAQ:AMED) 52-week high is $54.42 and the 52-week low is $31.16. This explains if the stock moves $-1.00, it will post a 52-week high. In event of $+71.44% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of Amedisys Inc, shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Amedisys Inc (NASDAQ:AMED) ratio came in at 46.25. The stock last ended the trading session at $53.42 and registered a market cap of $1.79B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Amedisys Inc (NASDAQ:AMED) PEG ratio is at 1.15.
1 Chart Pattern Every Investor Should Know